cjc-1295 ipamorelin peptide CJC-1295-5mg/Ipamorelin-5mg CJC-1295 Ipamorelin Blend 10mg Canada

65 YaoL.HaoX

Novo Nordisk files for FDA approval for CagriSema, the first once-weekly combination of GLP1 and amylin analogues owenhaskins Dec 19, 2025 2 min read Novo Nordisk has submitted a New Drug Application (NDA) to the FDA for once-weekly CagriSema (cagrilintide 2.4 mg and semaglutide 2.4 mg) injection, to be used with a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in adults with obesity or overweight in the presence of at least one weight-related comorbid condition

Insulin and IGF receptor signalling in neural-stem-cell homeostasis

doi: 10.1371/journal.pone.0048175 93 RohJLJangHKimEHShinD